Literature DB >> 18078474

Drugs and the kidney: more than a question of dose.

Derek G Waller.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 18078474      PMCID： PMC2198790          DOI： 10.1111/j.1365-2125.2007.03073.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  14 in total

1.  Absence of tolerance and toxicity to high-dose continuous intravenous furosemide in haemodynamically unstable infants after cardiac surgery.

Authors:  Maria M J van der Vorst; Joana E Kist-van Holthe; Jan den Hartigh; Albert J van der Heijden; Adam F Cohen; Jacobus Burggraaf
Journal:  Br J Clin Pharmacol       Date:  2007-04-18       Impact factor: 4.335

2.  Drug therapy in kidney disease.

Authors:  Jeffrey K Aronson
Journal:  Br J Clin Pharmacol       Date:  2007-05       Impact factor: 4.335

3.  The effect of screening for cardio-renal risk factors on drug use in the general population.

Authors:  Jarir Atthobari; Ron T Gansevoort; Sipke T Visser; Paul E de Jong; Lolkje T W de Jong-van den Berg
Journal:  Br J Clin Pharmacol       Date:  2007-12       Impact factor: 4.335

Review 4.  Clinical epidemiology of cardiovascular disease in chronic renal disease.

Authors:  R N Foley; P S Parfrey; M J Sarnak
Journal:  Am J Kidney Dis       Date:  1998-11       Impact factor: 8.860

Review 5.  Drug-induced acute kidney injury.

Authors:  Miet Schetz; Joseph Dasta; Stuart Goldstein; Thomas Golper
Journal:  Curr Opin Crit Care       Date:  2005-12       Impact factor: 3.687

Review 6.  Role of microalbuminuria in the assessment of cardiovascular risk in essential hypertension.

Authors:  Roberto Pontremoli; Giovanna Leoncini; Francesca Viazzi; Denise Parodi; Valentina Vaccaro; Valeria Falqui; Angelica Parodi; Simone Vettoretti; Elena Ratto; Giacomo Deferrari
Journal:  J Am Soc Nephrol       Date:  2005-03       Impact factor: 10.121

7.  Sublingual administration of furosemide: new application of an old drug.

Authors:  Laurent Haegeli; Hans Peter Brunner-La Rocca; Markus Wenk; Matthias Pfisterer; Jürgen Drewe; Stephan Krähenbühl
Journal:  Br J Clin Pharmacol       Date:  2007-09-13       Impact factor: 4.335

8.  Multiple-dose pharmacokinetics of peginterferon alfa-2b in patients with renal insufficiency.

Authors:  Samir K Gupta; Suzanne K Swan; Thomas Marbury; William Smith; Sherwyn Schwartz; Karen Kolz; David L Cutler
Journal:  Br J Clin Pharmacol       Date:  2007-06-06       Impact factor: 4.335

9.  The influence of continuous venovenous haemodialysis on the pharmacokinetics of multiple oral moxifloxacin administration to patients with severe renal dysfunction.

Authors:  H Stass; S Bührmann; A Mitchell; D Kubitza; J-G Möller; A Kribben; R R Wenzel; R F Schäfers
Journal:  Br J Clin Pharmacol       Date:  2007-06-06       Impact factor: 4.335

10.  Pharmacokinetics, safety, and efficacy of mycophenolate mofetil in combination with sirolimus or ciclosporin in renal transplant patients.

Authors:  Mark D Pescovitz; Flavio Vincenti; Marquis Hart; Larry Melton; John Whelchel; Shamkant Mulgaonkar; Diane McKay; Mimi Leung; Elizabeth Calleja; M René Bouw
Journal:  Br J Clin Pharmacol       Date:  2007-06-06       Impact factor: 4.335
View more
  2 in total

Review 1.  Pharmacokinetics and dosage adjustment in patients with renal dysfunction.

Authors:  Roger K Verbeeck; Flora T Musuamba
Journal:  Eur J Clin Pharmacol       Date:  2009-06-20       Impact factor: 2.953

2.  Current awareness: pharmacoepidemiology and drug safety.

Authors: 
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-06       Impact factor: 2.890
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.